Greene John
SEC insider (Form 3/4/5 filer). CIK 0001610732. Director at CRISPR Therapeutics AG (CRSP) and 2 other issuers. 10 reported Form 4/5 transactions since Sep 2024; latest on Jun 5, 2026. Located in BOSTON, MA.
Companies Greene John has filed insider reports for
- CRISPR Therapeutics AG (CRSP): Director
- NORTHROP GRUMMAN CORP /DE/ (NOC): Officer, CVP & Chief Financial Officer
- Discover Financial Services (DFS): Officer, EVP, Chief Financial Officer
Greene John
CIK: 0001610732
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (10 total)
- Jun 5, 2026CRSP
CRISPR Therapeutics AG
AwardDirectStock Option (Right to Buy)
13K shares- - Feb 11, 2026NOC
NORTHROP GRUMMAN CORP /DE/
AwardDirectRestricted Stock Rights
5.4K shares- - Feb 11, 2026NOC
NORTHROP GRUMMAN CORP /DE/
AwardDirectRestricted Performance Stock Rights
5K shares- - Jun 5, 2025CRSP
CRISPR Therapeutics AG
AwardDirectStock Option (Right to Buy)
13K shares- - May 18, 2025DFS
Discover Financial Services
DispositionDirect79.9K shares- - Feb 26, 2025CRSP
CRISPR Therapeutics AG
PurchaseDirect7K shares at avg. $44.85$314K - Feb 1, 2025DFS
Discover Financial Services
Tax PaymentDirect1.8K shares at avg. $201.09$370K - Jan 23, 2025DFS
Discover Financial Services
AwardDirect14.6K shares- - Dec 19, 2024DFS
Discover Financial Services
Tax PaymentDirect11.7K shares at avg. $169.27$2.0M - Dec 19, 2024DFS
Discover Financial Services
AwardDirect12.1K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 5, 2026 |  CRSP CRISPR Therapeutics AG | Award Stock Option (Right to Buy) | 13,000 | - | - | Direct |
| Feb 11, 2026 |  NOC NORTHROP GRUMMAN CORP /DE/ | Award Restricted Stock Rights | 5,362 | - | - | Direct |
| Feb 11, 2026 | NOC NORTHROP GRUMMAN CORP /DE/ | Award Restricted Performance Stock Rights | 4,981 | - | - | Direct |
| Jun 5, 2025 | CRSP CRISPR Therapeutics AG | Award Stock Option (Right to Buy) | 13,000 | - | - | Direct |
| May 18, 2025 |  DFS Discover Financial Services | Disposition | 79,943 | - | - | Direct |
| Feb 26, 2025 | CRSP CRISPR Therapeutics AG | Purchase | 7,000 | $44.85 | $313,948 | Direct |
| Feb 1, 2025 | DFS Discover Financial Services | Tax Payment | 1,840 | $201.09 | $370,006 | Direct |
| Jan 23, 2025 | DFS Discover Financial Services | Award | 14,630 | - | $0 | Direct |
| Dec 19, 2024 | DFS Discover Financial Services | Tax Payment | 11,702 | $169.27 | $1,980,798 | Direct |
| Dec 19, 2024 | DFS Discover Financial Services | Award | 12,109 | - | $0 | Direct |
1-10 of 10 transactions